Blood cancer discovery
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia.
Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, Yue Wei, Kelly S Chien, Ian Bouligny, Rashmi Kanagal-Shamanna, Ziyi Li, Anuya Natu, Mark Gurney, Alexandre Bazinet, Danielle Hammond, Alex Bataller, Gautam Borthakur, Nicholas J Short
Published: 202610.1158/2643-3230.BCD-25-0264
Abstract
Recent updates to monocyte count thresholds recognize oligomonocytic chronic myelomonocytic leukemia (OM-CMML) as an early form of CMML. However, the clinical validity of these changes remains uncertain without incorporating biological and genomic fa…
Preview only. Read the full abstract at the source